key: cord-0727721-4sapkp86
authors: Syamal, Mausumi
title: Literature‐guided recommendations for otolaryngologists during the COVID‐19 pandemic: A contemporary review
date: 2020-04-20
journal: Laryngoscope Investig Otolaryngol
DOI: 10.1002/lio2.389
sha: c1a3b17bfc2fa8ea695405dd297058bf9169f20f
doc_id: 727721
cord_uid: 4sapkp86

OBJECTIVE: The objective of this study was to review the current literature and guidelines on management of the novel coronavirus 2019 (COVID‐19 or 2019nCoV) with respect to the field of Otolaryngology. DESIGN: Contemporary literature review. METHODS: Systematic literature review of global medical literature databases and communications were queried to find all available literature recommendations, research, and guidelines applicable to otolaryngologists in the COVID‐19 pandemic. RESULTS: Guidance on personal protective equipment, office visits, and surgical scheduling, as well as recommendations for safe airway management and tracheotomy performance during the COVID‐19 pandemic were compiled and interpreted. CONCLUSIONS: Little guidance exists for otolaryngologists who are among the highest risk groups during the rapidly evolving COVID‐19 pandemic. This synthesis and compilation of global resources serve as a building block for further guidance during the epidemic. LEVEL OF EVIDENCE: NA.

In December 2019, a mysterious and rapidly growing cluster of respiratory illnesses originating in the Huanan Seafood Wholesale Market devastated the Wuhan, Hubei Province of China. 1,2 It was not until 3 January 2020 that the illness, named the 2019 novel coronavirus (2019-nCoV or was identified in samples of bronchoalveolar lavage fluid from a patient in Wuhan and was confirmed as the cause of the pneumonia. 3 Genome analysis indicated that 2019-nCoVis is a distinct subset of betacoronaviruses associated with human severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome. 3 The 2019-nCoV has close similarity to bat coronaviruses, and it has been suggested that bats were the primary source. 4 The presenting symptoms are fever, cough, and shortness of breath with potential progression to acute respiratory distress syndrome (ARDS) within 2 to 8 days. 4, 5 Spread occurs primarily through droplets and respiratory secretions (coughs and sneezes) placing otolaryngologists at high risk because of contact with the upper respiratory tract. The first documented global fatality of a physician was that of an otolaryngologist in Wuhan on 25 January 2020. 6 The median incubation period of the virus is estimated to be 5.1 days with 97.5% of those who develop symptoms doing so within 11.5 days. 7 Thus, there exists a time period during which patients are active viral shedders or "silent sentinels" before they become symptomatic, keeping in mind that some exhibit no symptoms. 8 The aim of this contemporary review was to identify opportunities to prevent transmission of the virus and to protect both patients and otolaryngologists, through interpretation of the literature viewed in the light of our daily practice.

Global medical literature databases and communications were queried to find all available literature recommendations, research, and guidelines applicable otolaryngologists in the COVID-19 pandemic. Ovid MEDLINE, PubMed, and COCHRANE databases were searched for all available years first for the terms "COVID-19" or "2019-nCoV."

Results including the terms "intubation" or "tracheostomy/tracheotomy" or "otolaryngology" or "airway" were then extracted. Articles for which full abstracts or papers were not retrievable or translatable were excluded. Additionally, internet Google and Bing search engine results for "COVID-19" and "otolaryngology" or "ear, nose and throat" were included. Results that were not relevant to otolaryngologists were excluded. All relevant search results were translated using translation software (whenever necessary) and sources cross-referenced.

Initial review included 1202 abstracts. Seven articles including case reports and case series met inclusion criteria and were included in the qualitative analysis. Search engine and cross-referencing results yielded an additional 22 resources. Eight articles were obtained from colleagues in their revision stages. Thirty-seven sources were deemed to contain relevant information for this compilation.

As there is no current vaccine for 2019-nCoV, the Centers for Disease Control and many other entities recommend that the best way to prevent infection is to avoid exposure. 9 However, avoiding exposure may not be possible or even an option. In one of the first case series documenting clinical course and a high mortality rate (15%), Huang and colleagues state "airborne precautions, such as a fit-tested N95 respirator, and other personal protective equipment (PPE) are strongly recommended. To prevent further spread of the disease in health-care settings that are caring for patients infected with 2019-nCoV." 5 Like other CoVs, 2019-nCoV is a positive stranded RNA virus with a spiked-glycoprotein envelope that is sensitive to ultraviolet rays and heat. 10 Furthermore, this virus can be inactivated by lipid solvents including ether (75%), ethanol, chlorine-containing disinfectant, peroxyacetic acid, and chloroform except for chlorhexidine. 11 This is important to note, as many surgical centers provide the option of chlorhexidine scrubs which should not be used if COVID-19 is a concern.

The current CDC recommendations for health care workers treating suspected or confirmed COVID-19 patients echo those abroad 12 recommending (a) nonsterile disposable patient examination gloves, (b) nonsterile, disposable patient isolation gowns, and (c) a surgical N95 (also referred as a medical respirator) for those who need protection from both airborne and fluid hazards (eg, splashes, sprays). 13 The use of Powered Air Purifying Respirators (PAPR) masks, especially in the surgical setting, is controversial. 14 Given the proximity to nasal-respiratory secretions, it is prudent for otolaryngologists to wear surgical N95 masks especially if performing any aerosolizing procedures (nasal sprays, nasal and laryngeal endoscopy, etc.). In a safety consensus statement for otolaryngologists, Givi and colleagues propose a risk-stratified approach to PPE combined with masking (surgical) the patient for high-risk aerosol-generating procedures. 15 At the time of drafting this document, N95 masks were scarce, prompting the CDC to advocate re-use of unsoiled masks and the "use homemade masks (eg, bandana, scarf) for care of patients with COVID-19 as a last resort." 16 Additionally, specific protocol must be followed in removing personal protective equipment to prevent contamination in the process.

In the first directed guide for otolaryngologists during the COVID-19 pandemic, Kai and colleagues in China share that "in view of the highrisk exposure of the ear, nose, throat and neck surgical staff, the nonacute and non-critical routine outpatient and ward work should be reduced as far as possible to cooperate with the national epidemic prevention and control." 17 The rationale stems from the thought that head and neck examination can evoke coughing, pharyngeal reflexes (gagging), and sneezing thereby producing droplets that can carry the virus splashed to a distance of 1 to 2 m, and make the virus aerosolized. The authors go further to state that certain procedures are at risk of spraying, such as nasal sprays/lavage, nosebleed control, and emergency tracheotomy. Accordingly, they recommend tertiary or droplet protection if those procedures are performed. The American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) recommends that "during in-office examinations, topical medications are more safely applied using pledgets rather than by spray." 18 In an international consensus statement for safety recommendations for head and neck surgery, Givi and colleagues suggest "postponing patients with benign disease (benign salivary or thyroid tumors or patients with hyperparathyroidism), or patients undergoing routine surveillance visits after treatment for head and neck cancer." 13 Although there may be a benefit to delay treatment for less aggressive head and neck cancers, it is recommended that the risks of COVID-19 transmission be carefully weighed against the risk of cancer progression and survival outcomes for advanced-stage or aggressive cancers. 19 Pre-screening procedures become mainstay, with pre-visit questionnaires inquiring about recent travel, fever, cough, or shortness of breath, with patients answering positively directed to COVID-19 testing sites or self-quarantine and symptom monitoring. 6 A unique symptom that may present to the otolaryngologist is anosmia. Evidences from South Korea (30% as major presenting symptom), Italy, China, Iran, France, and Germany (60% in 2019-nCoV+ patients) have all reported anosmia. 20 If exposure to a COVID-19 positive patient is known after an encounter, the CDC recommends a "conservative approach to…monitoring and restriction from work (14 days after last exposure)" with high and medium risk exposures (stratified based on PPE present on the provider and facemask on the patient). 9 If signs and symptoms develop, otolaryngologists should immediately report to their health facility as well as state and local health authorities who will direct further consultation and testing. can aerosolize virus present in the bloodstream. 13, 15 Notably, facial trauma such as "lacerations that involve mucosal surfaces should be treated as high risk." 14 

As COVID-19 has spread from the epicenter in China, several global colleagues developed airway consensus statements and guidelines to address the rate-limiting factor in transmission: respiratory droplet spread. Droplets are affected by gravity and may cause direct transmission from close contact or contribute to surface contamination (where the virus may remain active for hours to days). 25 and colleagues suggest that minimizing cuff leaks (this might mean accepting higher-than-normal cuff pressures or using a larger tube than we would normally suggest) to prevent aerosolization. There is also universal agreement that extubation must proceed with the same precautions as intubation.

In one of the largest cohorts of critically ill patients, Yang and colleagues studied 710 patients with COVID-19 pneumonia comparing survivors to non-survivors. 32 With 67% developing ARDS with a median time from admission to ICU to death being 7 days, an early tracheotomy procedure is not clinically indicated for COVID-19 positive patients and may results in vast consumption of PPE due to aerosolization during the procedure. 24 Tay and colleagues recommend that tracheotomy "procedures should be avoided or delayed (even well beyond 14 days)…until such time as the acute phase of infection has passed." 33 22 Performance of the tracheotomy may be in a negative-pressure operating room, or at the bedside in the ICU in negative-pressure rooms to reduce unnecessary transport. 29 Tracheotomy steps cited by Harrison and Ramsden were as follows:

• Most skilled anesthesia and otolaryngology staff perform the procedure, to ensure that the procedure is safe, accurate, and swift.

• Reduce team members to essential staff.

• Use mask, full face visor, fluid resistant gowns for all, consider double gloving.

• A cuffed, non-fenestrated tracheotomy tube should be used to avoid aerosolizing the virus.

• Every effort should be made not to pierce the cuff of the endotracheal tube.

• Advancement of the endotracheal tube should be performed prior to making the tracheotomy window.

• If possible, cease ventilation while the window in the trachea is being performed, and check that the cuff is still inflated before resuming ventilation.

• Ventilation should cease prior to tracheotomy tube insertion and ensure swift and accurate placement of tracheotomy tube with prompt inflation of the cuff.

• Confirm placement with end tidal CO 2 .

• Ensure that there is no leak from the cuff and that the tube is secured in position.

• Cuff pressures should be maintained between 25 and 30 cm H 2 O. 26 • Heat and moisture exchanger (HME) or viral filter should be placed on the tracheotomy to reduce shedding of the virus should the anesthesia tubing be disconnected. 35 • Avoid disconnecting HME but, if necessary, disconnect distal to HME.

In a 2003 series of three SARS coronavirus patients requiring tracheotomy (one urgent and two at day 14 of intubation) during which no medical team member was infected, the techniques were similar to those discussed above with additional tips to avoid diathermy which "can produce small particles that may act as a vehicle for the virus" and to perform only closed system suctioning with a viral filter. 36 Postoperatively, patients with a tracheotomy may be covered with a closed system identical to that used when a patient is connected to a mechanical ventilator to minimize the aerosol generation, especially given the suction requirements. 6 The Royal College of Anesthetists suggests avoiding humidified wet circuits which risk contamination if there is an unexpected circuit disconnection. Additionally, United Kingdom recommends avoiding changing the tracheotomy tube until COVID-19 has passed. It also advised to meticulously check the cuff for leaks and prevent any circuit disconnections. Only closed, in-line suctioning was recommended. In a series of six tracheotomy procedures performed on COVID-19 positive patients, posttracheotomy outcomes were mixed (two deaths, two comatose, and two remain hospitalized). 37 Notably no otolaryngologists were infected this series by Cui, and all tracheotomies were performed with PAPR.

The COVID-19 pandemic has fostered a great need for international medical collaboration. Although existing studies and consensus are emerging, the need for guidance for otolaryngologists is critical, as we are inevitably on the frontlines. As in any battle, armor is critical. As shortages of N95 masks and gowns emerge, the need to run PPE-lean systems requires planning, care, and education. As recommended by numerous agencies, elective and nonessential procedures and visits should be curtailed to preserve resources for those most at risk. Procedures contacting the areas of respiratory secretions where viral load is highest must be minimized. Exponential propagation of a pandemic occurs not by the "Symptomatic Sams." or those who exhibit symptoms, but rather through the "Silent Sentinels," those who shed the virus asymptomatically. It is hoped that this compilation will provide a foundation for guidance in a rapidly evolving landscape of the novel coronavirus pandemic and that it will help otolaryngologists by emphasizing our special risks, as well as the fact that our afebrile, asymptomatic patients may have and spread the virus. We should approach all patients as if they have COVID-19 until the pandemic has ended.

The author would like to acknowledge all the Otolaryngologists that have served and continue to serve on the frontlines of the COVID-19 pandemic. A special thank you to Robert T. Sataloff, MD, for his insights and guidance in the reviewing and editing process.

The authors declare no potential conflict of interest.

https://orcid.org/0000-0003-4525-4920 BIBLIOGRAPHY

Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle

Report of clustering pneumonia of unknown etiology in Wuhan City

China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Practical aspects of otolaryngologic clinical services during the 2019 novel coronavirus epidemic: an experience in Hong Kong

The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application

Providers must be alert for mild and asymptomatic COVID-19 patients. Otolaryngol Head Neck Surg

Division of Viral Diseases

Coronaviruses post-SARS: update on replication and pathogenesis

Features, evaluation and treatment coronavirus (COVID-19). Istituto Nazionale Tumori -IRCCS -Fondazione Pascale, Via Mariano Semmola 80100

Handbook of COVID-19 Prevention and Treatment

Recommended personal protective equipment (PPE) in hospitals/clinics under serious/emergency response level

To PAPR or not to PAPR?

Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic

Division of Viral Diseases

Recommendations of the surgical staff of the otolaryngology and neck on the protection of the new coronavirus infection

The American Academy of Otolaryngology-Head and Neck Surgery. Coronavirus-2019 update

Impact of the COVID-19 pandemic on the management of head and neck malignancies

Loss of sense of smell as marker of COVID-19 infection. ENTUK Royal College of Surgeons

Pediatric otolaryngology divisional and institutional preparatory response at Seattle Children's Hospital after COVID-19 regional exposure. Otolaryngol Head Neck Surg

Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion

A commentary on safety precautions for otologic surgery during the COVID-19 pandemic. Otolaryngol Head Neck Surg

Environmental Cleaning and Disinfection Recommendations: Interim Recommendations for US Households with Suspected/Confirmed Coronavirus Disease

Consensus statement: Safe Airway Society principles of airway management and tracheal intubation specific to the COVID-19 adult patient group

Intubation and ventilation amid the COVID-19 outbreak: Wuhan's experience

Recommendations for Airway Management in a patient with suspected coronavirus (2019-nCoV) infection. The Anesthesia Patient Safety Foundation (APSF)

Recommendations for tracheal intubation in critically ill patients with noval coronavirus disease 2019. Chinese Society of Anesthesiology Task Force on Airway Management

Guidance for surgical tracheostomy and tracheostomy tube change during the COVID-19 pandemic. ENTUK Organization. The Royal College of Surgeons

The South African Society of Otorhinolaryngology published guidelines for tracheostomy and tracheostomy tube changes during the COVID-pandemic

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Surgical considerations for tracheostomy during the COVID-19 pandemic: lessons learned from the severe acute respiratory syndrome outbreak

COVID-19 pandemic: what every Otolaryngologist-Head & Neck surgeon needs to know for safe Airway Management. Otolaryngol Head Neck Surg

Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia

Safe tracheostomy for patients with severe acute respiratory syndrome

How to cite this article: Syamal M. Literature-guided recommendations for otolaryngologists during the COVID-19 pandemic: A contemporary review